AAAAAA
Results:
1-14
|
Results: 14
Authors:
BRUN E
OHLSSON T
ERLANDSSON K
KJELLEN E
SANDELL A
TENNVALL J
WENNERBERG J
STRAND SE
Citation: E. Brun et al., EARLY PREDICTION OF TREATMENT OUTCOME IN HEAD AND NECK-CANCER WITH 2-(18)FDG PET, Acta oncologica, 36(7), 1997, pp. 741-747
Authors:
JOHNSSON A
KJELLEN E
WENNERBERG J
PERO R
Citation: A. Johnsson et al., METOCLOPRAMIDE AS A MODULATOR OF CISPLATIN - EFFECTS ON PHARMACOKINETICS AND CISPLATIN-DNA ADDUCTS IN TUMOR AND NORMAL TISSUE, Anti-cancer drugs, 7(4), 1996, pp. 483-488
Authors:
ROJAS A
DENEKAMP J
JOHNS H
KJELLEN E
TSANG R
NILSSON P
STRATFORD MRL
DENNIS MF
JOINER MC
Citation: A. Rojas et al., NICOTINAMIDE AS A REPAIR INHIBITOR IN-VIVO - STUDIES USING SINGLE ANDFRACTIONATED X-RAY DOSES IN MOUSE SKIN AND KIDNEYS, Radiation research, 145(4), 1996, pp. 419-431
Authors:
ZATTERSTROM UK
BRUN E
WILLEN R
KJELLEN E
WENNERBERG J
Citation: Uk. Zatterstrom et al., TUMOR ANGIOGENESIS AND PROGNOSIS IN SQUAMOUS-CELL CARCINOMA, OF THE HEAD AND NECK, Head & neck, 17(4), 1995, pp. 312-318
Authors:
AKERVALL J
JIN Y
WENNERBERG J
ZATTERSTROM UK
KJELLEN E
MERTENS F
WILLEN R
MANDAHL N
HEIM S
MITELMAN F
Citation: J. Akervall et al., CHROMOSOMAL-ABNORMALITIES INVOLVING 11Q13 ARE ASSOCIATED WITH POOR-PROGNOSIS IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, European journal of cancer, 31A, 1995, pp. 387-387
Authors:
ENGELLAU J
ZATTERSTROM UK
KJELLEN E
Citation: J. Engellau et al., TIME INTERVALS VERSUS PROGNOSIS IN COMBINED TREATMENT OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, European journal of cancer, 31A, 1995, pp. 403-403
Authors:
KJELLEN E
PERO RW
BRUN E
EWERS SB
JARLMAN O
KNOOS T
MALMSTROM P
TENNVALL J
KILLANDER D
OLSSON A
SHENG Y
WENNERBERG J
Citation: E. Kjellen et al., A PHASE I II EVALUATION OF METOCLOPRAMIDE AS A RADIOSENSITIZER IN PATIENTS WITH INOPERABLE SQUAMOUS-CELL CARCINOMA OF THE LUNG/, European journal of cancer, 31A(13-14), 1995, pp. 2196-2202
Authors:
PERO RW
OLSSON A
SHENG Y
HUA J
MOLLER C
KJELLEN E
KILLANDER D
MARMOR M
Citation: Rw. Pero et al., PROGRESS IN IDENTIFYING CLINICAL RELEVANCE OF INHIBITION, STIMULATIONAND MEASUREMENTS OF POLY ADP-RIBOSYLATION, Biochimie, 77(5), 1995, pp. 385-393
Authors:
ZATTERSTROM UK
ENGELLAU J
JOHANSSON MC
WENNERBERG J
KJELLEN E
Citation: Uk. Zatterstrom et al., RADIATION EFFECTS ON S-PHASE DURATION, LABELING INDEX, POTENTIAL DOUBLING TIME AND DNA DISTRIBUTION IN HEAD AND NECK-CANCER XENOGRAFTS, Acta oncologica, 34(2), 1995, pp. 205-211
Authors:
LINDHOLM CE
KJELLEN E
NILSSON P
WEBER L
HILL S
Citation: Ce. Lindholm et al., PROGNOSTIC FACTORS FOR TUMOR RESPONSE AND SKIN DAMAGE TO COMBINED RADIOTHERAPY AND HYPERTHERMIA IN SUPERFICIAL RECURRENT BREAST CARCINOMAS, International journal of hyperthermia, 11(3), 1995, pp. 337-355
Authors:
OLSSON A
SHENG YZ
KJELLEN E
PERO RW
Citation: A. Olsson et al., IN-VIVO TUMOR MEASUREMENT OF DNA-DAMAGE, DNA-REPAIR AND NAD POOLS AS INDICATORS OF RADIOSENSITIZATION BY METOCLOPRAMIDE, Carcinogenesis, 16(5), 1995, pp. 1029-1035
Authors:
AKERVALL JA
JIN YS
WENNERBERG JP
ZATTERSTROM UK
KJELLEN E
MERTENS F
WILLEN R
MANDAHL N
HEIM S
MITELMAN F
Citation: Ja. Akervall et al., CHROMOSOMAL-ABNORMALITIES INVOLVING 11Q13 ARE ASSOCIATED WITH POOR-PROGNOSIS IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Cancer, 76(5), 1995, pp. 853-859
Authors:
TENNVALL J
LUNDELL G
HALLQUIST A
WAHLBERG P
WALLIN G
TIBBLIN S
LOWHAGEN T
AKERMAN M
BLOMGREN H
KJELLEN E
KRISTOFFERSSON A
Citation: J. Tennvall et al., COMBINED DOXORUBICIN, HYPERFRACTIONATED RADIOTHERAPY, AND SURGERY IN ANAPLASTIC THYROID-CARCINOMA - REPORT ON 2 PROTOCOLS, Cancer, 74(4), 1994, pp. 1348-1354
Authors:
WENNERBERG J
KJELLEN E
LYBAK S
RYDELL R
PERO R
Citation: J. Wennerberg et al., BIOCHEMICAL MODULATION OF CHEMOTHERAPY AND RADIOTHERAPY IN HEAD AND NECK-CANCER, Anticancer research, 13(6B), 1993, pp. 2501-2506
Risultati:
1-14
|